1. Home
  2. ATRO vs HCM Comparison

ATRO vs HCM Comparison

Compare ATRO & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astronics Corporation

ATRO

Astronics Corporation

N/A

Current Price

$54.99

Market Cap

2.4B

Sector

Industrials

ML Signal

N/A

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

N/A

Current Price

$13.17

Market Cap

2.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATRO
HCM
Founded
1968
2000
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
ATRO
HCM
Price
$54.99
$13.17
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
★ $91.75
$21.14
AVG Volume (30 Days)
★ 517.4K
35.6K
Earning Date
11-10-2026
07-30-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 276.09
N/A
EPS
★ 2.36
N/A
Revenue
★ $862,128,000.00
N/A
Revenue This Year
$19.65
$14.16
Revenue Next Year
$12.42
$11.95
P/E Ratio
$24.71
★ $5.49
Revenue Growth
★ 8.39
N/A
52 Week Low
$47.58
$9.77
52 Week High
$99.89
$16.33

Technical Indicators

Market Signals
Indicator
ATRO
HCM
Relative Strength Index (RSI) 40.91 38.06
Support Level $54.10 $13.00
Resistance Level $63.72 $14.74
Average True Range (ATR) 4.07 0.39
MACD 0.10 -0.16
Stochastic Oscillator 28.19 6.52

Price Performance

Historical Comparison
ATRO
HCM

About ATRO Astronics Corporation

Astronics Corporation is a provider of technologies to the aerospace, defense, and electronics industries, offering high-performance electrical power generation and distribution systems, motion systems, lighting and safety systems, avionics products, systems certification, aircraft structures, and automated test systems. The company operates through two reportable segments, Aerospace and Test Systems. The Aerospace segment designs and manufactures products for the aerospace and defense industry and generates the majority of revenue, while the Test Systems segment designs, develops, manufactures, and maintains automated test systems for the aerospace and defense, communications, and mass transit industries. The company derives the majority of its revenue from the United States.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.

Share on Social Networks: